Clinical studies of ABMT in non-Hodgkin's lymphoma.
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D002469:Cell Separation; D002648:Child; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D007239:Infections / Q000209:etiology; D008223:Lymphoma / Q000145:classification / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D011379:Prognosis; D013997:Time Factors; D014182:Transplantation, Autologous; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents